Rolf Rutten

Biography

 Mr. Rolf Jan Rutten is the Founder and Chief Executive Officer/Managing Director at Audion Therapeutics BV. Mr. Rutten has over fifteen years experience in management and business development in the pharmaceutical and biotechnology industry. He held various global commercial positions with Akzo Nobel and Kreatech Biotechnology, a molecular diagnostics company, before leading the commercialization of the IP portfolio of TNO pharma. He is responsible for all activities of the European subsidiaries of Clinquest Group. He was also a Co-Founder of Dybly AG, a Basel-based cardiovascular company.  

Research Interest

 management and business development in the pharmaceutical and biotechnology